Currently, there are 124.85M common shares owned by the public and among those 76.86M shares have been available to trade.
The company’s stock has a 5-day price change of 16.92% and -87.09% over the past three months. VOR shares are trading -84.06% year to date (YTD), with the 12-month market performance down to -89.47% lower. It has a 12-month low price of $0.13 and touched a high of $1.87 over the same period. VOR has an average intraday trading volume of 890.78K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -64.05%, -72.65%, and -80.50% respectively.
Institutional ownership of Vor Biopharma Inc (NASDAQ: VOR) shares accounts for 42.34% of the company’s 124.85M shares outstanding.
It has a market capitalization of $22.11M and a beta (3y monthly) value of -0.54. The earnings-per-share (ttm) stands at -$1.51. Price movements for the stock have been influenced by the stock’s volatility, which stands at 35.87% over the week and 20.62% over the month.
Earnings per share for the fiscal year are expected to increase by 61.86%, and 32.13% over the next financial year. EPS should grow at an annualized rate of 33.72% over the next five years, compared to -38.02% over the past 5-year period.
Looking at the support for the VOR, a number of firms have released research notes about the stock. Wedbush stated their Outperform rating for the stock in a research note on July 26, 2022, with the firm’s price target at $18. Goldman coverage for the Vor Biopharma Inc (VOR) stock in a research note released on April 27, 2022 offered a Neutral rating with a price target of $6. H.C. Wainwright was of a view on December 17, 2021 that the stock is Buy, while Robert W. Baird gave the stock Outperform rating on December 03, 2021, issuing a price target of $38. Oppenheimer on their part issued Outperform rating on December 02, 2021.
